Beyond Genomic Testing: A New Immune Response Profiling Platform Aligned with 2025 AACR Trends
Exhibitor: CELLENVISION COMPANY LIMITED
Date: 2025-06-18
Booth No.: N915
As global oncology enters a new era of immunotherapy and cell-based treatments, traditional precision medicine tools focused solely on genomic alterations have proven insufficient for accurately predicting therapeutic outcomes. In response to the 2025 American Association for Cancer Research (AACR) spotlight on tumor evolution and the tumor immune microenvironment (TiME), a Taiwan-based research team has introduced the Personalized Precision Oncology and Tumor Immune Microenvironment Monitoring Platform, offering clinical and drug development teams a more realistic and actionable view of immune dynamics.
This platform integrates real-time liquid biopsy, immune cell activity analysis, and preliminary TIL selection technologies. It is positioned as a research-use and clinical decision-support tool to assist in immunotherapy and cell therapy strategy development. By profiling immune–tumor interactions at the cellular level, it fills key gaps left by conventional sequencing-based methods.
Addressing Unmet Needs in the Global Precision Oncology Landscape
At the 2025 AACR Annual Meeting, experts emphasized that changes in the tumor immune microenvironment and cellular heterogeneity are becoming critical indicators for therapeutic prediction. This platform is aligned with that consensus, providing dynamic, operable, and quantifiable data at the cellular level, enabling both clinical and R&D teams to strengthen therapeutic decision-making frameworks.
Target Users and Collaboration Opportunities
This platform is particularly suited for:
- Companies developing immunotherapies and cell-based therapies
- Medical institutions conducting personalized oncology research
- Research teams exploring next-generation immune response biomarkers and TIL selection strategies
Platform Use Disclaimer
This platform is intended for research or clinical support use only and is not a substitute for diagnosis or treatment. All results are for physician reference only. Final clinical decisions should be made by healthcare professionals based on comprehensive diagnostic information.
More Exhibitor's Press Release
- Link-Best debuted at BIO Asia Exhibition. Products attracted attention and Ignited Spark. LINK-BEST BIOSCIENCE CO., LTD. / 2025-08-11
- GoldenBiotech-Advancing First-line treatment of Meta. PanCa GOLDEN BIOTECHNOLOGY CORP. / 2025-08-10
- GlobalBio: 國鼎生技-開發Antroquinonol 造福抗癌研究治療 GOLDEN BIOTECHNOLOGY CORP. / 2025-08-10
- 現場校正、抽檢應用 攜帶式測量儀 XIN TOP CORPORATION / 2025-08-07
- Honya Medical Strengthens Local Presence and Expands Toward Global Clinical Excellence HONYA MEDICAL CO., LTD. / 2025-07-30
- Honya’s MiSaver: A New Frontier in Treating Heart Damage After Heart Attacks HONYA MEDICAL CO., LTD. / 2025-07-30
- AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Technology Platform TFBS BIOSCIENCE, INC. / 2025-07-25
- Visit Us at BIO Asia–Taiwan 2025! July 24 – July 27 GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-25
- GBC CellBio™ a2000 has been recognized with a 2025 Edison Award. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- GBC AI Biotech Building Officially Commissioned. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- Your Invitation to Innovation – Booth M412 Forum MAJOR SCIENCE CO.,LTD / 2025-07-24
- Ecotek Engineering Corp.: Your Integrated Partner for Biopharma Facility and Process Equipment Solut MAJOR SCIENCE CO.,LTD / 2025-07-24
- About major science - Create life sciences research instruments through quality and innovation MAJOR SCIENCE CO.,LTD / 2025-07-24
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-07-24
- MarkerX Unveils MyeloTrak™ at BIO Asia, Redefining Multiple Myeloma Management with Non-invasive, Pr MARKER X CO., LTD. / 2025-07-23
- CancerFree Biotech Selected for OIST Startup Accelerator Program CANCERFREE BIOTECH LTD. / 2025-07-23
- AI Sparks a New Wave in Cancer Research: How a Taiwanese Startup Is Breaking Lab Bottlenecks and Ad CANCERFREE BIOTECH LTD. / 2025-07-23
- Transin Biomedical showcases the innovative strength of smart medical devices TRANSIN BIOMEDICAL CO., LTD. / 2025-07-23
- TaiMed Biologics Hosts Interactive Activities at BIO Asia 2025 to Promote HIV Awareness TAIMED BIOLOGICS INC. / 2025-07-22
- A Pioneer for Over Two Decades, Cell-Bio Biotechnology to Showcase Comprehensive Solutions at BioAsi CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-22